Genflow Biosciences plc (LON:GENF – Get Free Report)’s share price fell 7.7% during trading on Thursday . The stock traded as low as GBX 1.80 and last traded at GBX 1.80. Approximately 320,415 shares were traded during mid-day trading, a decline of 85% from the average session volume of 2,163,648 shares. The stock had previously closed at GBX 1.95.
Genflow Biosciences Stock Performance
The firm has a market capitalization of £10.20 million, a P/E ratio of -5.42 and a beta of 2.30. The stock has a 50 day moving average of GBX 2.02 and a 200-day moving average of GBX 2.05.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
- Astera Labs’ Post-Earnings Pullback May Be Last Chance to Buy Below $360
- McDonald’s Stock Sell-Off: Justified Warning or Buying Opportunity?
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
